本页面由Tiger Trade Technology Pte. Ltd.提供服务

Stoke Therapeutics, Inc.

22.86
-1.2950-5.36%
成交量:15.77万
成交额:364.94万
市值:14.75亿
市盈率:-6.86
高:24.06
开:24.06
低:22.65
收:24.15
52周最高:40.22
52周最低:20.32
股本:6,452.62万
流通股本:4,561.25万
量比:0.39
换手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-3.3325
每股收益(LYR):-0.1163
净资产收益率:-61.10%
总资产收益率:-35.87%
市净率:4.27
市盈率(LYR):-196.58

数据加载中...

2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/08

重要事件披露

Form 8-K - Current report
2026/05/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/07

重要事件披露

Form 8-K - Current report
2026/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/27

重要事件披露

Form 8-K - Current report
2026/03/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/16

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

重要事件披露

Form 8-K - Current report
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/12/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities